Hospice News June 29, 2022
Jim Parker

Congressional legislators are casting doubts on regulatory oversight of Medicare Advantage plans over concerns about spending, claims denials, and end-of-life care.

Several lawmakers expressed these reservations during a House Energy and Commerce Committee’s Oversight and Investigation subcommittee hearing that focused on the Medicare Advantage program.

“Improper claim denials and increased use of prior authorizations are preventing beneficiaries from receiving the care they need,” Energy and Commerce Chairman Frank Pallone, Jr. (D-N.J.) said during the hearing. “While there are many plans that appear to be acting responsibly, some are not, and these bad actors are costing taxpayers money and, more importantly, jeopardizing the health of seniors.”

Officials from several federal agencies testified, including the U.S. Department of Health & Human Services...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Congress / White House, Govt Agencies, Insurance, Medicare Advantage, OIG, Survey / Study, Trends
Medicare Advantage Organizations: 7 Ways to Ensure Your Document Management Platform Offers Full Automation
Fewer Medicare Advantage Plans Are Offering Home-Based Care Services For 2025
Medicare Advantage and Part D Programs to Remain in the Enforcement Spotlight in 2025
Why aren't Medicare Advantage enrollees using supplemental benefits?
Alignment Healthcare names new president as insurer eyes growth

Share This Article